Unknown

Dataset Information

0

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.


ABSTRACT:

Background & aims

Non-alcoholic fatty liver disease is an increasing health issue that develops rather unnoticed with obesity, type 2 diabetes mellitus and metabolic syndrome. We investigated prevalence, determinants and associated metabolic abnormalities of non-alcoholic fatty liver disease in the largest population-based cohort to date.

Methods

Biochemical characteristics, type 2 diabetes mellitus and metabolic syndrome were determined in the Lifelines Cohort Study (N = 167,729), a population-based cohort in the North of the Netherlands. Non-alcoholic fatty liver disease was defined as Fatty Liver Index (FLI)≥60. Exclusion criteria were age <18 years, immigrants, missing data to assess FLI and metabolic syndrome, excessive alcohol use, previous-diagnosed hepatitis or cirrhosis and non-fasting blood sampling.

Results

Out of 37,496 included participants (median age 44 years, 62.1% female), 8,259 (22.0%) had a FLI≥60. Individuals with a FLI≥60 were more often male, older, obese, had higher levels of hemoglobinA1c, fasting glucose, liver enzymes, total cholesterol, low-density lipoprotein cholesterol, triglycerides, c-reactive protein and leucocytes and lower high-density lipoprotein cholesterol (all P<0.0001). Participants with a FLI≥60 showed higher prevalence of type 2 diabetes mellitus (9.3% vs. 1.4%), metabolic syndrome (54.2% vs. 6.2%), impaired renal function (20.1% vs. 8.7%) and cardiovascular disease (4.6% vs. 1.6%) (all P<0.0001). Multivariable logistic analysis showed that smoking, hemoglobin, leucocytes, c-reactive protein, platelets, alanine aminotransferase, alkaline phosphatase, albumin, impaired renal function (OR 1.27, 95%CI 1.15-1.41), metabolic syndrome (OR 11.89, 95%CI 11.03-12.82) and its individual components hyperglycemia (OR 2.53, 95%CI 2.34-2.72), hypertension (OR 1.89, 95%CI 1.77-2.01) and reduced high-density lipoprotein cholesterol (OR 3.44, 95%CI 3.22-3.68) were independently associated with suspected non-alcoholic fatty liver disease (all P<0.0001).

Conclusion

Twenty-two percent (22.0%) of the population in the North of the Netherlands is suspected to suffer from non-alcoholic fatty liver disease, coinciding with a significant increased risk of type 2 diabetes mellitus, metabolic syndrome, cardiovascular disease and impaired renal function.

SUBMITTER: van den Berg EH 

PROVIDER: S-EPMC5289609 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.

van den Berg Eline H EH   Amini Marzyeh M   Schreuder Tim C M A TC   Dullaart Robin P F RP   Faber Klaas Nico KN   Alizadeh Behrooz Z BZ   Blokzijl Hans H  

PloS one 20170202 2


<h4>Background & aims</h4>Non-alcoholic fatty liver disease is an increasing health issue that develops rather unnoticed with obesity, type 2 diabetes mellitus and metabolic syndrome. We investigated prevalence, determinants and associated metabolic abnormalities of non-alcoholic fatty liver disease in the largest population-based cohort to date.<h4>Methods</h4>Biochemical characteristics, type 2 diabetes mellitus and metabolic syndrome were determined in the Lifelines Cohort Study (N = 167,729)  ...[more]

Similar Datasets

| S-EPMC8830644 | biostudies-literature
| S-EPMC6894836 | biostudies-literature
| S-EPMC9631254 | biostudies-literature
| S-EPMC6490340 | biostudies-literature
| S-EPMC5471107 | biostudies-other
| S-EPMC8301658 | biostudies-literature
| S-EPMC6502065 | biostudies-literature
| S-EPMC7977080 | biostudies-literature
| S-EPMC10471967 | biostudies-literature
| S-EPMC9788291 | biostudies-literature